PML is a component of a multiprotein complex, termed nuclear bodies, and the PML protein was originally discovered in patients suering from acute promyelocytic leukaemia (APL). APL is associated with a reciprocal chromosomal translocation of chromosomes 15 and 17, which results in a fusion protein comprising PML and the retinoic acid receptor a. The PML genomic locus is approximately 35 kb and is subdivided into nine exons. A large number of alternative spliced transcripts are synthesized from the PML gene, resulting in a variety of PML proteins ranging in molecular weight from 48 ± 97 kDa. In this review we summarize the data on the known PML isoforms and splice variants and present a new unifying nomenclature. Although, the function/s of the PML variants are unclear, all PML isoforms contain an identical N-terminal region, suggesting that these sequences are indispensable for function, but dier in their C-terminal sequences. The N-terminal region harbours a RING-®nger, two B-boxes and a predicted a-helical Coiled-Coil domain, that together form the RBCC/TRIM motif found in a large family of proteins. In PML this motif is essential for PML nuclear body formation in vivo and PML-homo and hetero interactions conferring growth suppressor, apoptotic and antiviral activities. In APL oligomerization mediated by the RBCC/TRIM motif is essential for the transformation potential of the PML-RARa fusion protein. Oncogene (2001) 20, 7223 ± 7233. 
Introduction
PML is a part of a multiprotein complex called PML nuclear bodies, ND10 or PODs (PML oncogenic domains) (reviewed in Hodges et al., 1998; Sternsdorf et al., 1997a) . It is a heterogenous group of nuclear multi-protein complexes (Brasch and Ochs, 1992) which do not colocalize with any of the known nuclear substructures (Ascoli and Maul, 1991; Dyck et al., 1994; Raska et al., 1992; Stuurman et al., 1992; Weis et al., 1994) . PML was originally discovered in patients suering from the haematopoietic malignancy acute promyelocytic leukaemia (APL), associated with a reciprocal chromosomal translocation of chromosomes 15 and 17. This translocation results in a fusion protein comprising PML and the retinoid acid receptor a (RARa) (de TheÂ et al., 1991; Goddard et al., 1991; Kakizuka et al., 1991; Kastner et al., 1992) . The expression of the fusion protein PML-RARa is sucient for transformation in APL cells and the development of leukaemia (Altabef et al., 1996; Brown et al., 1997; Grisolano et al., 1997) . APL is characterized by a block in dierentiation of promyelocytes, and unlike normal cells, PML is dispersed into hundreds of tiny dots in the nucleus and the cytoplasm in APL cells (Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994) .
One striking feature of APL cells is that treatment with all-trans retinoid acid (ATRA) restores the normal pattern of PML nuclear bodies (Daniel et al., 1993) and the dierentiation block of the promyelocytes is released (Huang et al., 1988) . Treatment of APL patients with ATRA often leads to complete remission, which is however, mostly short-lived (see review by Degos and Wang in this issue). More recently, it has been demonstrated that treatment with low doses of arsenic trioxide also represents a successful alternative treatment for APL, inducing apoptosis in leukaemic cells Zhu et al., 1997) . Disintegration of PML nuclear bodies is believed to play a key role in the development of APL, which is consistent with the observation that the normal PML protein has growth-and transformation-suppressing properties (Ahn et al., 1995; Koken et al., 1995; Le et al., 1996; Mu et al., 1994; Quignon et al., 1998) . Other studies on PML and PML nuclear bodies in cell growth control have been carried out using cell lines derived from PML knockout mice, revealing tumour suppressor and pro-apoptotic functions for PML (Wang et al., 1998) . Recently, it has been shown that PML might be involved in p53-dependent apoptosis (Fogal et al., 2000; Guo et al., 2000) and also in the regulation of gene expression (Wu et al., 2001; Zhong et al., 2000) . More extensive reviews on PML function are presented in this volume.
A large number of proteins are described to localize to PML nuclear bodies. Some of these namely, PML, Sp100 and ISG20 are inducible by IFN a/b (Type I) and IFN g (Type II) Gongora et al., 1997; GroÈ tzinger et al., 1996; Lavau et al., 1995; Stadler et al., 1995) suggesting that PML nuclear bodies could be part of a cellular defence mechanism.
In support of this notion, PML nuclear bodies are often targeted and disrupted by various viral regulatory proteins (reviewed in Seeler and Dejean, 1999; Sternsdorf et al., 1997a) , possibly leading to an inactivation of these defence systems and subsequent expression of viral genes (see review by Regad and Chelbi-Alix; and Everett in this issue) . Another important PML nuclear body constituent is the small ubiquitin-related protein SUMO-1 , found covalently linked to PML (Kamitani et al., 1998a; Muller et al., 1998; Sternsdorf et al., 1997b) . Modi®cation of proteins by SUMO-1 is proposed to either, regulate speci®c protein ± protein interactions, target proteins to speci®c subcellular compartments, or to prevent degradation by the ubiquitin-dependent pathway (Desterro et al., 1998; Everett et al., 1998; Mahajan et al., 1997; Matunis et al., 1996; Muller et al., 1998; Saitoh et al., 1997) . It has also been proposed that SUMO modi®cation has a role in protein degradation ; see review by de TheÂ in this issue). The functional implications of PML SUMO modi®cation is discussed by Seeler and Dejean in this volume.
The PML protein itself contains three cysteine-rich zinc-binding domains, a RING-®nger, two B-boxes (B1 and B2) and a predicted a-helical Coiled-Coil domain, which together form the RBCC motif (Borden, 1998; Saurin et al., 1996) or recently termed TRIpartite Motif or TRIM (Reymond et al., 2001) . The RBCC/ TRIM motif is present in all PML isoforms and in the PML/RARa fusion protein and is discussed extensively below. It is notable that two other members of the RBCC/TRIM family, TIF1 and Rfp, also become oncogenic as a result of chromosomal translocations (Hasegawa et al., 1996; Klugbauer and Rabes, 1999; Le Douarin et al., 1995) .
Identi®cation of alternative spliced PML transcripts
The PML gene consist of nine exons and several alternative spliced PML transcripts have been described (de TheÂ et al., 1991; Fagioli et al., 1992; Goddard et al., 1991; Kakizuka et al., 1991; Kastner et al., 1992) . Interestingly, all of the PML isoforms contain the N-terminal region comprising the RBCC/ TRIM motif, but dier either in the central region or in the C-terminal region, due to alternative splicing ( Figure 1 and Table 1a ,b). In addition to the RBCC/ TRIM, all PML isoforms (excluding the b/c variants) contain the three characterized SUMO-1 modi®cation sites (at position 65 in the RING ®nger, 160 in the B1-Box and 490 in the NLS) and a bipartite nuclear localization signal, suggesting that the functionality of these motifs are relevant to most PML isoforms. It is notable that in all of the cell lines examined to date, the diering PML splice variants are more or less equally expressed , although total cell extracts blotted with the PML 5E10 mAb show some variation in protein levels (H de TheÂ , personal communication) .
The PML isoforms can be divided into seven groups, which we are designating as PML I ± VII, on the basis of sequence dierences at the C-terminus. (Figure 1 Figure 1 Exon assembly and structural domains of the PML isoforms. All PML isoforms share the N-terminal region containing the RBCC motif. The seven dierent C-termini are generated by alternative usage of 3' exons, resulting in PML isoforms of varying sizes (total length of each isoform is given on the right). SUMOylation sites (S) at amino acid positions 65, 160 and 490 are indicated. *Retained intron and Table 1a ). A further division into sub-groups a/b/c re¯ects the alternative splicing of exons 4, 5 and 6 (Table 1b) . It has been shown that PML III and PML IV exist without exon 5 (de TheÂ et al., 1991; and that PML V can exist without exons 5 and 6 or 4, 5 and 6 , although the sequences for the latter two isoforms are not available. Recently a comprehensive study of all human proteins, belonging to the RBCC/TRIM-family, has been described (Reymond et al., 2001) . In this study, one new PML isoform (PML VIIb/TRIM19 theta) and one new alternative spliced variant (PML VIb/TRIM19 iota/eta) were identi®ed. There is some evidence to suggest that all PML isoforms can exist as a/b/c variants , although further studies are needed to con®rm this. Since the b and c variants are missing the NLS, they are likely to be cytoplasmic. It should be noted that there are two proposed initiation methionines resulting in PML translation products that dier by 22 amino acids. The functions 
Isoforms
Exons References PML 1 1-2-3-4-5-6-7a-8a-9 . . . PML4 PML-1 (Goddard et al., 1991) TRIM19 alpha (Reymond et al., 2001) PML II 1-2-3-4-5-6-7a-7b . . . PML2 PML-3 (Goddard et al., 1991) TRIM19 gamma (Reymond et al., 2001) TRIM19 delta (Reymond et al., 2001) TRIM19 kappa (Reymond et al., 2001) PML III 1-2-3-4-5-6-7a-7ab retained intron-7b . . . PML-L (de TheÂ et al., 1991) PML IV 1-2-3-4-5-6-7a-8a-8b . . . PML3 Myl ( Missing intron seq. GTAGGGAG before exon 7a. Note: There is evidence to suggest that all isoforms can exist as a/b/c variants of the PML splice variants are not known, alternative splicing could add new functional domains to the protein or may be an important mechanism for generating diverse PML-binding interfaces for a variety of factors.
Isoform speci®c interactions
An extensive number of studies have been carried out aimed at identifying speci®c PML interacting proteins (Table 2) . However, careful analysis of the particular PML isoform used in these studies often reveals that only one isoform has been studied. It still remains to be shown if the observed PML-protein interactions are speci®c to individual PML isoforms. Here we focus on several PML isoform-speci®c interactions.
Recently, an isoform speci®c interaction between p53 and PML IV has been demonstrated (Fogal et al., 2000) . These data showed p53 recruited to PML nuclear bodies by PML IV or by co-expression of SUMO-1 and its E2 conjugating enzyme hUBC9. The p53-PML IV interaction is mediated by the p53 core domain and the C-terminal part of PML IV, as p53 does not interact with PML-RAR a or PML III (Fogal et al., 2000) . Furthermore overexpression of PML IV in cells expressing wild type p53 results in a reduction of cell survival, suggesting that recruitment of p53 into PML nuclear bodies (by PML IV) modulates the survival functions linked to PML nuclear bodies. Interestingly, relocalization of p53 to PML nuclear bodies enhances p53 transactivation in a promotor speci®c manner only when PML IV is SUMO-1 modi®ed, suggesting that p53 activity is modulated by PML nuclear body relocalization (Fogal et al., 2000) .
PML also plays a role in transcriptional regulation. The PML IV isoform has been shown to speci®cally repress transcription by interacting with histone deacetylase (HDAC) (Wu et al., 2001) . In contrast PML VI does not interact with HDAC (Li et al., 2000) and PML/RARa interacts poorly, suggesting that the C-terminal region of PML IV protein is required for HDAC interaction. In APL this transcription-silencing function of PML might be disrupted (by the expression of PML-RARa) and may lead to altered chromatin remodelling and gene expression patterns and subsequent onset of leukaemia (Saha et al., 1998) .
The retinoblastoma protein (pRB), a key protein in regulating cell growth, also colocalizes with PML nuclear bodies . PML IV interacts with the nonphosphorylated fraction of the retinoblastoma protein (pRB), with the RBCC/TRIM motif required for optimal stability of the complex . However, the PML C-terminus is also important for pRB interaction, as PML II exhibited a weaker interaction compared to PML IV . Surprisingly, the non-phosphorylated form of pRB also interacts with PML/RARa despite the absence of the PML IV C-terminus, although other cellular proteins might be involved in the formation of a PML/RARa-pRB complex in vivo. Interestingly, PML, but not PML/RARa, has an inhibitory eect on pRB transactivation, suggesting that an interaction between PML and pRB might be important in the regulation of cell dierentiation and proliferation . PML/RARa could antagonize this eect and thereby contribute to a deregulation of dierentiation and proliferation in APL cells.
Breakpoints in APL
Two major breakpoint positions have been described in APL (de TheÂ et al., 1991; Goddard et al., 1991;  Kakizuka et al., 1991; Kastner et al., 1992; Pandol® et al., 1991) . These breakpoints mark exon ± exon boundaries and are located between exons 3 and 4 (amino acid 394; Figure 1 ) and between exons 6 and 7 (amino acid 552; Figure 1 ). It is interesting to note that the breakpoints are positioned before and after the central region in the PML protein (exons 4, 5 and 6) that is alternatively spliced, although the relevance of this observation is unclear. In APL, similar splicing occurs and PML-RARa and RARa-PML transcripts have been identi®ed without exon 5 (de TheÂ et al., 1991; Kastner et al., 1992) . All the PML-RARa fusion proteins contain the RBCC/TRIM motif, but not the variable C-terminal domain. The dierent breakpoints also result in PML fusion proteins that dier in the presence of the PML NLS, SUMOylation sites and the caspase proteolytic cleavage site implicated in PML-RARa degradation (Nervi et al., 1998) . Only the RARa-PML transcripts contain the C-terminal domain of the PML protein (from exon 4 or exon 7, depending on the breakpoint). As the function of the C-terminal domain of the PML protein is not known it is dicult to predict the eect of the RARa ± PML fusion protein Li et al., 1997) , although the RARa-PML fusion has been shown to accelerate APL in transgenic mice (Pollock et al., 1999) .
The RBCC/TRIM family PML belongs to a family of proteins that contain a RBCC or recently termed TRIM motif (Borden, 1998; Reymond et al., 2001) , (Table 3) . The RBCC/TRIM motif was ®rst identi®ed in the Xenopus transcriptional regulator XNF7 (Reddy et al., 1992) and comprise several cysteine-rich zinc binding domains (RING ®nger and B-box) followed by a predicted a-helical Coiled-Coil domain (reviewed by Borden, 1998; Saurin et al., 1996) , (Figure 2) . A recent and comprehensive study of the RBCC/TRIM family, using a functional genomics approach, has identi®ed and characterized a large number of novel family members (Reymond et al., 2001) . The genes encoding each of the RBCC/ TRIM family members are scattered throughout the human genome, but there are two distinct clusters on chromosomes 11p15 and 6p21 ± 23 suggesting that duplication of an ancestral RBCC/TRIM gene at these genomic locations may have occurred (Reymond et al., 2001) . The order of the sub-domains is conserved, with the RING ®nger, B-box and coiled-coil domains arranged from the N to C-terminus. However, the number of B-boxes can vary between dierent family members (Table 3 ) and the number of RBCC/TRIM domains is not ®xed since RNF21 has two RBCC/ TRIM domains in tandem (Orimo et al., 2000a) . The Oncogene PML isoforms and the RBCC/TRIM motif K Jensen et al C-terminal regions are variable, but subfamilies sharing domains such as the ret proto-oncogene-encoded ®nger protein (RFP)-like domain (also known as the B30.2 domain) and the NHL domain can be de®ned. A shared C-terminal domain between RBCC/TRIM members may also indicate common functions/activities, for example, the chromatin-associated TIF1 family share a C terminal bromodomain (Jacobson et al., 2000; Venturini et al., 1999) . The RBCC/TRIM proteins can homo-interact through their coiled-coil domains, and in the case of RFP, this interaction requires an intact B-box, but not the RING ®nger (Cao et al., 1997) . The correct folding of the B-box may be required to help orient the coiledcoil prior to homomultimerization and to maintain the correct overall structure of the protein (Cao et al., 1997) . The coiled-coil domain of RFP is also required for interaction with Enhancer of polycomb (EPC) (Shimono et al., 2000) and for heterodimerization with PML (Cao et al., 1998) . In the latter case, this interaction is mediated through the distal two helices of the coiled-coil domain, whereas the proximal helix mediates homo-RFP interactions (Cao et al., 1997 (Cao et al., , 1998 . In contrast to these ®ndings, the entire RBCC/ TRIM domain is required for multimer formation and interaction of TIF1b to the KRAB (KruÈ ppel-associated box) transcriptional repressor domain. This interaction is entirely speci®c for the TIF1b RBCC/TRIM domain since substitution of RBCC/TRIM motifs from related proteins such as TIF1a or MID1 do not bind the KRAB domain (Peng et al., 2000) . In addition, chimaeric RBCC/TRIM proteins containing either the RING, B-box or coiled-coil motifs from MID1 fail to bind KRAB (Peng et al., 2000) . The RBCC domain can therefore function as a single integrated structure with each sub-domain contributing towards oligomerization and/or ligand binding.
The RBCC/TRIM motif and PML function
The RING ®nger motif is a cysteine-rich zinc-binding module found in many functionally diverse proteins from plants to man, and was ®rst identi®ed in the human protein RING1 (Freemont, 1993) . The family is large (fourteenth most common motif in the human genome), and a number of RING-speci®c functions have been postulated. The most cited is for RING domains acting as protein ± protein interaction modules (Borden, 1998; Kentsis and Borden, 2000) and in particular to mediate E3 ubiquitin ligase activities by interacting and promoting E2-dependent ubiquitin conjugation (Freemont, 2000) . The PML RING domain has been subjected to extensive structural and functional analyses. A three-dimensional solution structure has revealed the conserved RING structural elements, namely two zinc atoms ca 14 A Ê apart bound via a cross-brace arrangement of Cys and single His ligands (Borden, 1998; Borden et al., 1995a) . Mutations in PML of these conserved zinc-binding ligands (Cys) disrupt PML nuclear body formation in vivo (Borden et al., 1995a; Kastner et al., 1992) . Furthermore, these mutations are correlated with a loss of PML growth suppression Mu et al., 1994) , apoptotic and anti-viral activities Regad et al., 2001) , see review by Regad and ChelbiAlix in this issue.
The PML RING structure also prompted a series of mutagenesis studies aimed at testing surface residues and PML nuclear body formation in vivo (Boddy et Figure 2 Schematic of the PML RBCC/TRIM motif. The insert pictures are three-dimensional structural representations of the three sub-domains; the PML RING ®nger domain (Borden et al., 1995a) , the XNF7 B-box domain (Borden et al., 1995b) and an idealized heterodimeric alpha-helical coiled-coil. Zinc atoms are represented as grey/white spheres, beta-strands as arrows and alphahelices as ribbons. The spatial arrangement of three sub-domains is unknown as is the stoichiometry of the predicted coiled-coil, although in PML the B2 B-box leads directly into this region al., 1997). Several striking mutations that localize to a particular surface region (Glu63DArg; Lys65DGlu; Glu63Lys65DAla; Lys65Lys68DAla) result in abnormally large PML nuclear aggregates in vivo that are not linked to aberrant PML protein turnover (Boddy et al., 1997) . Co-transfection studies of these mutants with PML-RARa however, prevents the formation of PML-RARa speckles (E Duprez and P Freemont, unpublished observations), suggesting a dominant mutant phenotype in terms of sub-nuclear localization. The dependence on an intact RING ®nger for PML nuclear body formation in vivo may relate to speci®c protein ± protein interactions mediated by the RING. Several studies have shown PML RING-speci®c interactions with the SUMO-1 E2 enzyme UBC9 (Duprez et al., 1999) , the proline rich homeodomain PRH (Topcu et al., 1999) , and the viral proteins Z (Borden et al., 1998a) , IE1 (Ahn et al., 1998) and Tas (Regad et al., 2001) . Interestingly, the PML RING is SUMO modi®ed (Kamitani et al., 1998b) , although other studies are in disagreement (Duprez et al., 1999; . Whether PML nuclear body formation in vivo is directly linked to ecient SUMO-1 modi®cation of PML is still a matter of considerable debate ; see reviews by de TheÂ ; and Seeler and Dejean in this issue), although it is clear that the RING is essential for PML nuclear body formation in vivo.
Adjacent to the RING domain in PML are two distinct cysteine-rich motifs, termed B-boxes (B1 and B2). Both motifs are small (42 and 46 residues respectively) and bind zinc but dier in the number and spacing of conserved Cys and His ligands . A solution structure of a related B-box (XNF7) showed B-boxes to be small elongated domains with a single well-ordered zinc-binding site (Borden et al., 1995b) . One surface of the XNF7 B-box is hydrophobic and a general model for B-box dimerization (or hetero protein interaction) has been proposed that utilizes this surface and a second zincbinding site (Borden et al., 1995b) . In terms of PML, substitution of conserved zinc ligands in B1 and/or B2 disrupt PML nuclear body formation in vivo but do not prevent PML-PML oligomerization . Together with the RING ®nger, the PML Bboxes also exert biological activity in terms of PML growth suppressor function . Interestingly the B1 SUMOylation site is critical for recruitment of the 11S proteosomal subunit to PML nuclear bodies .
In other RBCC/TRIM proteins only one copy of the B-box motif is present, but inspection of the whole family reveals a conserved residue spacing between the RING, B-box and coiled-coil domains (Table 3 and Reymond et al., 2001) . This strongly suggests that the overall architecture of the RBCC/TRIM motif is highly conserved, perhaps relating to the motif acting as a scaold for higher-order protein ± protein interactions (Peng et al., 2000) . In support of this idea, deletion studies of the RBCC/TRIM protein RFP, have shown the B-box to be important for facilitating homo-interactions of the coiled-coil region (Cao et al., 1997) . Molecular modelling suggests that the position and orientation of the B-box (adjacent to the coiledcoil) would be critical for the correct alignment of the a -helices that form the coiled-coil (see below). Interestingly, unlike the RING and coiled-coil motifs, the B-box is only found in RBCC/TRIM family members suggesting that it is a critical determinant of the overall motif and its function (Reymond et al., 2001) .
Coiled-coil structures are formed from inter-wound a-helices which produce rod-like structures and their presence in protein sequences can be predicted (Lupas, 1996) . Coiled-coils mediate both homo and heterodimeric interactions, as well as higher order multimer interactions, for example trimers/hexamers (Peng et al., 2000) . The weakly predicted coiled-coil region for PML comprises residues 229 ± 323. Several studies have shown that these regions (without the RING and Bboxes) are essential for PML multimerization as well as heterodimerization with PML-RARa (Grignani et al., 1996; Kastner et al., 1992; Le et al., 1996; Perez et al., 1993) . The coiled-coil region is also essential for PML nuclear body formation and full growth suppressor activity in vivo . More importantly, the formation of high molecular weight complexes through the coiled-coil is essential for the PML-RARa retinoic acid response (Grignani et al., 1999 ; see review by Evans in this issue). These studies are in general agreement with other RBCC/TRIM proteins where removal of the coiled-coil region prevent the formation of high molecular complexes (Peng et al., 2000; Reymond et al., 2001) .
In summary the RBCC/TRIM motif in PML is essential for PML nuclear body formation in vivo as well as PML growth suppressor, apoptotic and antiviral activities. These and other PML functions appear dependent on higher-order homo or hetero protein ± protein interactions as mediated by the RBCC/TRIM motif.
Disease linked RBCC/TRIM mutations
Mutations within certain RBCC/TRIM proteins have been described that lead to genetically inherited disorders. The gene encoded by MID1 is a microtubule-associated protein and mutations within this gene have been shown to underlie the X-linked form of Opitz Syndrome and correlate with a disruption in the microtubule-associated pattern Quaderi et al., 1997) . Although mutations in the Cterminus of the protein are predominant and lead to the accumulation of large cytoplasmic aggregates, a number of N-terminal mutations have now been described, including one that is predicted to truncate the protein before the B-box motifs (Cox et al., 2000) . The MID1 protein can homo-interact through its RBCC/TRIM motif and forms large protein complexes within the cell . N-terminal mutations aect the intracellular location of the protein in a manner quite distinct from the C-terminal mutations, since these mutated proteins do not form cytoplasmic aggregates but are instead found diuse throughout the cytoplasm (Cox et al., 2000) . MID1 mutants missing the B-box domain are also found in the nucleus, consistent with the idea that the B-box may be required for MID1 cytoplasmic retention (Cox et al., 2000) , as has also been found for RFP (Cao et al., 1997) . Similarly, mutations in the RBCC/TRIM protein MUL result in Mulibrey nanism (Avela et al., 2000) . All four of the MUL mutations described cause a frameshift and predict a truncated protein, and in three of them, as in Opitz Syndrome, the disease phenotype does not seem to arise directly from loss of function related to the RBCC/TRIM motif (Avela et al., 2000) .
Summary and future prospects
The large number of alternatively spliced PML transcripts generates a variety of PML proteins that dier in their C-terminal sequences (from 8 to 330 residues). The observation that particular PML isoforms mediate speci®c protein interactions suggests that PML splice variants could have potentially diverse cellular functions. All PML isoforms contain identical N-terminal sequences (552 residues) that comprise the RBCC/TRIM motif, a motif that is also found in a large family of unrelated proteins. The RBCC/TRIM domain mediates homo/hetero PML-protein interactions and PML nuclear body formation and is essential for PML growth suppressor, apoptotic and anti-viral activities in vivo. In APL, the motif confers the transformation potential of the PML-RARa fusion protein. Although a number of pleotropic cellular functions have been assigned to PML, less is known about PML molecular function and little about the functional roles of the PML isoforms. Given that all the isoforms appear to be expressed at similar levels (in cell lines studies to date), it will be important to de®ne precisely the sub-nuclear localization patterns for each isoform, identify isoform-speci®c protein partners and test isoform hetero-oligomerization and interactions with known PML-targeted viral proteins. Our current understanding of PML splice variants would suggest overlapping but distinct functions for each isoform. One of the big challenges ahead therefore, will be to identify speci®c functions attributable to individual PML isoforms and to understand the functional crosstalk between them, given that they can likely heterodimerize. In terms of APL, it will be increasingly important to study the reciprocal RARa-PML fusion transcripts and their contribution to the APL phenotype, given that they would re¯ect alternative PML splice variants.
